Mark Douglas Smith - Apr 3, 2023 Form 4 Insider Report for Phreesia, Inc. (PHR)

Role
Director
Signature
/s/ Alexis Lyons, as Attorney-in-Fact for Smith Mark Douglas
Stock symbol
PHR
Transactions as of
Apr 3, 2023
Transactions value $
-$182,397
Form type
4
Date filed
4/5/2023, 04:36 PM
Previous filing
Dec 6, 2022
Next filing
May 26, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PHR Common Stock Options Exercise $33K +7K +43.45% $4.71* 23.1K Apr 3, 2023 Direct F1
transaction PHR Common Stock Sale -$199K -6.5K -28.12% $30.69 16.6K Apr 3, 2023 Direct F1, F2
transaction PHR Common Stock Sale -$15.9K -500 -3.01% $31.77 16.1K Apr 3, 2023 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PHR Stock Option Options Exercise $0 -7K -9.7% $0.00 65.2K Apr 3, 2023 Common Stock 7K $4.71 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 18, 2023.
F2 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.33 to $31.19 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.60 to $31.93 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 27,306 of the original 84,193 shares underlying the option vested became exercisable on September 5, 2019, with 25% of the remainder vesting on September 5, 2019, and 75% of the remainder vesting in thirty-six (36) equal monthly installments thereafter.